Skip to main content
. 1998 Oct;36(10):2964–2969. doi: 10.1128/jcm.36.10.2964-2969.1998

TABLE 3.

Precision of ultrasensitive HIV-1 MONITOR Testa

Specimen and no. of input RNA copies/mlb Mean calculated RNA concn (no. of copies/ml) RNA concn (no. of copies/ml)
Within-run variation
Between-day variation
Between-operator variation
Total
Minimum Maximum SD (no. of RNA copies/ml) CV (%) SD (no. of RNA copies/ml) CV (%) SD (no. of RNA copies/ml) CV (%) SD (no. of RNA copies/ml) CV (%)
VQA
    250 375 165 1,287 111 29.5 57 15.2 38 10.1 130 34.7
 25,000 27,844 13,695 90,526 8,348 30.0 5,023 18.0 0c 0c 9,742 35.0
Clinical
    500 710 355 1,202 132 18.7 90 12.7 0c 0c 160 22.5
 25,000 29,444 17,380 55,540 6,111 20.8 1,988 6.8 0c 0c 6,426 21.8
a

These calculations were performed as described in the EP5T guideline of the National Committee for Clinical Laboratory Standards (19) for within-run, between-day, and between-operator variations and total precision. Between-day variation includes variation between runs; between-run variation within 1 day could not be calculated because each operator performed only one run per day. The total number of replicates for each specimen is 100. 

b

VQA are dilutions of the viral stock from ACTG. Clinical specimens were obtained from HIV-positive patients. 

c

The estimate of variance was negative and was set to zero in accordance with the guideline of the National Committee for Clinical Laboratory Standards (19).